Development and psychometric evaluation of the death risk perception scale for advanced cancer patients
- PMID: 38811953
- PMCID: PMC11134621
- DOI: 10.1186/s12904-024-01467-7
Development and psychometric evaluation of the death risk perception scale for advanced cancer patients
Erratum in
-
Correction: Development and psychometric evaluation of the death risk perception scale for advanced cancer patients.BMC Palliat Care. 2024 Jun 25;23(1):161. doi: 10.1186/s12904-024-01491-7. BMC Palliat Care. 2024. PMID: 38918756 Free PMC article. No abstract available.
Abstract
Background: An accurate perception of death risk is a prerequisite for advanced cancer patients to make informed end-of-life care decisions. However, there is to date no suitable scale to measure death risk perception. This study was to develop and psychometrically test the death risk perception scale (DRPS) for advanced cancer patients.
Methods: Process of instrument development and psychometric evaluation were used. First, qualitative research, a literature review, brainstorming, a Delphi study, and cognitive interviews were conducted to construct a pretest scale of death risk perception. Second, a scale-based survey was administered to 479 advanced cancer patients. Item, exploratory factor, and confirmatory factor analyses were employed to optimize the scale. The Cronbach's alpha was calculated as a reliability analysis. The validity analysis included construct, convergent, discriminant, and content validity values.
Results: A three-dimension, 12-item scale was developed, including deliberative, affective, and experiential risk perception. The confirmatory factor analysis supported the three-factor model with satisfactory convergent and discriminant validity levels. The Cronbach's alpha coefficient for internal consistency was 0.807 and scale-level content validity index was 0.98.
Conclusions: The 12-item DRPS is a reliable and valid instrument for assessing the level of death risk perception in advanced cancer patients. More studies are needed to examine its structure and robustness prior to use.
Keywords: Advanced cancer; Palliative care; Psychometrics; Risk perception.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Psychometric assessment of the Chinese version of the Problems and Needs in Palliative Care questionnaire-short version in advanced cancer patients.BMC Palliat Care. 2019 Aug 6;18(1):68. doi: 10.1186/s12904-019-0450-5. BMC Palliat Care. 2019. PMID: 31387575 Free PMC article.
-
Designing and psychometric evaluation of disease-related fear scale (D-RFS) in adults with epilepsy: A sequential exploratory mixed methods design.Epilepsy Behav. 2020 Sep;110:107169. doi: 10.1016/j.yebeh.2020.107169. Epub 2020 Jun 3. Epilepsy Behav. 2020. PMID: 32504981
-
Development and psychometric testing of a new instrument to measure factors influencing women's breast cancer prevention behaviors (ASSISTS).BMC Womens Health. 2016 Jul 22;16:40. doi: 10.1186/s12905-016-0318-2. BMC Womens Health. 2016. PMID: 27444675 Free PMC article.
-
[Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].Encephale. 2004 Sep-Oct;30(5):437-46. doi: 10.1016/s0013-7006(04)95458-9. Encephale. 2004. PMID: 15627048 Review. French.
-
[Development and Psychometric Evaluation of the Ischemic Stroke Distress Scale (ISDS)].J Korean Acad Nurs. 2023 Feb;53(1):12-27. doi: 10.4040/jkan.22090. J Korean Acad Nurs. 2023. PMID: 36898682 Review. Korean.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources